<?xml version="1.0" encoding="UTF-8"?>
<ref id="b21-1031825">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hehlmann</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Lauseker</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Jung-Munkwitz</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-alpha in newly diagnosed chronic myeloid leukemia</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2011</year>;
  <volume>29</volume>(
  <issue>12</issue>):
  <fpage>1634</fpage>â€“
  <lpage>1642</lpage>.
  <pub-id pub-id-type="pmid">21422420</pub-id>
 </mixed-citation>
</ref>
